{"id":"NCT03481634","sponsor":"Novartis Pharmaceuticals","briefTitle":"Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema","officialTitle":"A Two-year, Three-arm, Randomized, Double-masked, Multicenter, Phase III Study Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Adult Patients With Visual Impairment Due to Diabetic Macular Edema","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-07-23","primaryCompletion":"2020-11-11","completion":"2021-10-18","firstPosted":"2018-03-29","resultsPosted":"2022-10-28","lastUpdate":"2023-01-30"},"enrollment":566,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetic Macular Edema"],"interventions":[{"type":"DRUG","name":"Brolucizumab","otherNames":["RTH258","ESBA1008"]},{"type":"DRUG","name":"Aflibercept","otherNames":["Eylea"]}],"arms":[{"label":"Brolucizumab 3 mg","type":"EXPERIMENTAL"},{"label":"Brolucizumab 6 mg","type":"EXPERIMENTAL"},{"label":"Aflibercept 2 mg","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study was to evaluate the efficacy and safety of brolucizumab in treatment of patients with visual impairment due to diabetic macular edema (DME).","primaryOutcome":{"measure":"Change From Baseline in Best-corrected Visual Acuity (BCVA) at Week 52","timeFrame":"Baseline, Week 52","effectByArm":[{"arm":"Brolucizumab 3 mg","deltaMin":7.3,"sd":0.66},{"arm":"Aflibercept 2 mg","deltaMin":10.6,"sd":0.67}],"pValues":[{"comp":"OG001 vs OG002","p":"<0.001"},{"comp":"OG000 vs OG002","p":"0.227"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":6},"locations":{"siteCount":116,"countries":["United States","Argentina","Australia","Austria","Canada","Colombia","Israel","Italy","Japan","Netherlands","Portugal","Puerto Rico","Spain","United Kingdom"]},"refs":{"pmids":[],"seeAlso":["https://www.novctrd.com/ctrdweb/patientsummary/patientsummaries?patientSummaryId=1194"]},"adverseEventsSummary":{"seriousAny":{"events":58,"n":190},"commonTop":["Hypertension","Conjunctival haemorrhage - Study eye","Nasopharyngitis","Urinary tract infection","Diabetic retinal oedema - Fellow eye"]}}